Navigating the Immunotherapy Maze
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come…
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
With the help of a huge €66M Series A round last week, the German startup…
With the success of CAR T-cell therapies and other innovative medicines in this area, immuno-oncology…
The German biotech Immatics will partner with GSK and could receive more than €1B from…
An international research team has found a new type of T-cell that could lead to…
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be…
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…